Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
NUVL
#912
Nuvalent, Inc. Class A Common Stock
101.950
0
-0.51%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-0.51%
Aylık değişim
-3.57%
6 aylık değişim
+7.37%
Yıllık değişim
+7.37%
Önceki kapanış
102.470
0
Open
101.950
0
Bid
Ask
Low
101.950
0
High
101.950
0
Hacim
98
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
NUVL
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
42.88 M
51.27 M
58.63 M
66.16 M
73.18 M
—
Valuation ratios
Enterprise value
2.69 B
4.69 B
14.29 B
4.27 T
5.49 T
18.24 T
Price to earnings ratio
-8.94
-17.56
-35.07
-19.92
-17.19
-64.88
Price to sales ratio
715.11
—
—
—
—
—
Price to cash flow ratio
-10.37
-22.15
-44.42
-28.09
26.57
-41.76
Price to book ratio
1.46
3.11
6.32
4.86
5.86
9.92
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.17
0.17
0.23
0.3
0.38
Return on equity %
0.16
0.18
0.18
0.24
0.34
0.43
Return on invested capital %
7 406.59
11.86 K
15 K
14.8 K
4 493.41
2 817.91
Gross margin %
100
—
—
—
—
—
Operating margin %
7 899.48
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
7 982.76
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
33.07
24.54
22.83
20.96
15.27
54.06
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.84
1.31
1.71
2.79
3.79
3.82
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
13.23
9.51
12.36
16.84
18.87
60.93
Net current asset value per share
13.34
9.62
12.48
17.05
19.16
61.79
Tangible book value per share
13.08
9.32
12.03
16.11
17.17
56.09
Working capital per share
12.94
9.23
11.93
16.24
17.9
57.2
Book value per share
13.08
9.32
12.03
16.11
17.17
56.09
Haberler
Nuvalent 4. çeyrek zararını açıkladı, akciğer kanseri ilacı için FDA kararını bekliyor
Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug
Drugmakers turn to AI to speed trials, regulatory submissions
Nuvalent Inc hissesi 112,89 dolar ile 52 haftalık zirveyi gördü
Nuvalent Inc stock hits 52-week high at 112.89 USD
FDA, Nuvalent’in ROS1 pozitif KHDAK tedavisi için NDA başvurusunu kabul etti
FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment
Nuvalent (NUVL) chief legal officer Miller sells $676k in stock
Nuvalent CSO Pelish sells shares worth $501,752
Nuvalent (NUVL) chief development officer sells $721k in stock
What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)
3 Biotech Stocks With Major 2026 Catalysts